8 studies found for:    Mepolizumab | asthma | Phase 3
Show Display Options
Rank Status Study
1 Unknown  Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
Conditions: Asthma;   Viral Infection
Interventions: Drug: Mepolizumab;   Drug: Placebo
2 Completed Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
Condition: Asthma
Interventions: Drug: Mepolizumab;   Drug: Placebo
3 Completed Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Condition: Asthma
Interventions: Drug: Mepolizumab IV;   Drug: Mepolizumab SC;   Drug: IV placebo and SC placebo
4 Recruiting Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Condition: Asthma
Interventions: Biological: Mepolizumab;   Drug: Placebo;   Drug: SOC
5 Active, not recruiting A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
Condition: Asthma
Interventions: Biological: Mepolizumab;   Drug: SOC
6 Completed A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects
Condition: Asthma
Intervention: Biological: Mepolizumab
7 Active, not recruiting MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Condition: Asthma
Intervention: Drug: Mepolizumab
8 Recruiting Cross-sectional Study for Identification and Description of Severe Asthma Patients
Condition: Asthma
Intervention: Drug: Short Acting Beta Agonist (SABA)

Indicates status has not been verified in more than two years